INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
Rhea-AI Summary
INOVIO (NASDAQ:INO) announced its Q3 2025 financial results will be released after market close on November 10, 2025.
The company will host a live conference call and webcast at 4:30 p.m. ET the same day to discuss results and provide a business update. The webcast is listen-only with a live Q&A with analysts and will be archived for 90 days at the company investor site.
Positive
- None.
Negative
- None.
News Market Reaction 12 Alerts
On the day this news was published, INO gained 6.87%, reflecting a notable positive market reaction. Argus tracked a peak move of +9.5% during that session. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $9M to the company's valuation, bringing the market cap to $142M at that time.
Data tracked by StockTitan Argus on the day of publication.
The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2025-financial-results-on-november-10-2025-302594838.html
SOURCE INOVIO Pharmaceuticals, Inc.